Amprion Empowers People Through Quality Brain Aging. In this short video, discover how Amprion’s groundbreaking Prion Early Detection Science can bring a significant impact in the fight to end Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. Amprion’s discovery technology tracks the prions (or misfolded proteins) in the brain before the start of any clinical symptoms. Early detection is the keystone in finding effective treatments. We’re fighting to end Alzheimer’s and Parkinson’s before we lose another generation. Join the fight!
Early Diagnosis for Alzheimer’s & Parkinson’s
The work that has been done by Amprion, it is so significant because it has never been done before. It is a game-changer. We’re trying to solve a dire lack of treatments that are available for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.
The number of people affected by these diseases is huge, not only in the US, but in the whole world. So that’s really exciting to think that we can help to improve that. It means that the family can take care of these patients. They can make a plan of how we are going to help these people. Because right now, it’s uncertain. They don’t know. At Amprion, we detect biomarkers at very, very low concentrations prior to there being any disease. And therefore, we enable early diagnosis for Alzheimer’s and Parkinson’s.
We believe that we might be able to extend early detection to decades or more. By understanding where you are on the spectrum, you can make changes. One could make changes from lifestyle. People believe that diet or exercise, other lifestyle changes. On the other hand, we believe that one could manage these diseases and their brain health through the next generation of drugs. We help people do what we call preventive brain care and quality brain aging.